RTTNews | Jun 24, 2021 07:24AM EDT

07:24 Thursday, June 24, 2021 (RTTNews) - Aravive Says Positive Initial Results From Phase 1b Study Of AVB-500 With Cabozantinib In Clear Cell Renal Carcinoma

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved